Search Results

You are looking at 1 - 10 of 1,090 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics and Genomics to Diverse Communities: The Power of Partnership

Deborah J. MacDonald, Kathleen R. Blazer, and Jeffrey N. Weitzel

health centers have traditionally led the diffusion of new technologies into community practice, commercial availability and marketing of genetic testing have accelerated the uptake of testing in the community setting, where clinicians are often

Full access

Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment

Reha-Baris Incesu, Simone Morra, Lukas Scheipner, Andrea Baudo, Letizia Maria Ippolita Jannello, Mario de Angelis, Carolin Siech, Anis Assad, Zhe Tian, Fred Saad, Shahrokh F. Shariat, Felix K. H. Chun, Alberto Briganti, Ottavio de Cobelli, Luca Carmignani, Sascha Ahyai, Nicola Longo, Derya Tilki, Markus Graefen, and Pierre I. Karakiewicz

Background To date, no population-based study has reported a survival benefit in most contemporary community-based patients with clear-cell metastatic renal cell carcinoma (ccmRCC) receiving active treatment, relative to their historical

Full access

Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer

Ahmed A. Hussein, Umar Iqbal, Zhe Jing, Yousuf Ramahi, Holly Houenstein, Stephanie Newman, Blake Peterson, Katarina Krajacic, Adeena Samoni, Bo Xu, Norbert Sule, Gissou Azabdaftari, Eric C. Kauffman, James L. Mohler, Michael Kuettel, and Khurshid A. Guru

at LPCC and communicated to outside pathologists. Patients who were presented at LPCC but received treatment outside our hospital were contacted to determine the final treatment received. Concordance between recommendations made by community

Full access

The Community Oncologist: Part of the Solution

Michael A. Kolodziej

tangible way to improve the care of patients. As a community oncologist, it has been my pleasure to be on the frontlines, as a witness to and participant in this reformation. However, we do have our challenges. Community oncologists are being assaulted on

Full access

NCCN Guidelines and the International Community

John H. Ward

from panels composed of oncology professionals from NCCN member institutions. Over time, these guidelines have become more and more accepted by the oncology community in the United States. They are also extensively used internationally. As reported by

Full access

Best Practices for Addressing the Health Needs of the LGBTQ+ Community in Oncology Care

Presented by: Bláz Bush, Paula Chambers Raney, Shail Maingi, Mandi L. Pratt-Chapman, and Scout

Moderated by: Clifford Goodman

Who Comprises the LGBTQ+ Community? LGBTQ+ is an abbreviation for lesbian, gay, bisexual, transgender, queer, and more, which encompasses genderqueer, nonbinary, questioning, queer, intersex, and asexual, among others. According to Bláz Bush

Full access

Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance

Allison Lipitz-Snyderman, Jessica Kennington, Brooke Hogan, Deborah Korenstein, Leonard Kalman, Suresh Nair, Peter Yu, Paul Sabbatini, and David Pfister

evident than in oncology, where community health systems have begun to partner with academic medical centers, which are attempting to extend their reach into the community setting, where 85% of cancer care is delivered. 6 , 7 Several NCI

Full access

Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer

Supriya G. Mohile, Allison Magnuson, Chintan Pandya, Carla Velarde, Paul Duberstein, Arti Hurria, Kah Poh Loh, Megan Wells, Sandy Plumb, Nikesha Gilmore, Marie Flannery, Marsha Wittink, Ronald Epstein, Charles E. Heckler, Michelle Janelsins, Karen Mustian, Judith O. Hopkins, Jane Liu, Srihari Peri, and William Dale

their primary care providers (PCPs), 12 community oncology practices should be equipped to recognize common age-related concerns. Despite the rapidly increasing population of older patients with cancer, most oncologists have received little geriatrics

Full access

Keeping Up in the Community

Daniel P. Mirda

Tempero: How in the world can a community oncologist keep up to date with new treatment options for patients with cancer? Mirda: There are many challenges to treating patients with the latest and best therapies tailored to their particular

Full access

CLO19-034: The Clinical Outcomes of Next-Generation Sequencing Testing at a Community Oncology Practice

Christie Hancock and Jacob Bitran

at our community hospital. Methods: Patients in our oncology clinic that underwent NGS testing of their tumor were reviewed. Specifically, the patient’s age, gender, diagnosis, date of diagnosis, previous lines of treatment, date of NGS testing, and